Drug intelligence / Profile preview

Colzen

Development stage
Unknown
Lead developer
Silvestre Labs
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules, Hydrogel Systems → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
Administration
Topical
01

Overview

Colzen is a biocompatible bioactive wound dressing developed by Silvestre Labs, a subsidiary of the Axis Biotec Group. It is composed of a synergistic combination of type I collagen, calcium alginate, and cerium nitrate. The dressing is indicated for the management of various wound types, including burns, pressure ulcers, diabetic foot ulcers, and surgical wounds. Its mechanism of action involves collagen promoting granulation and epithelialization, calcium alginate managing exudate by forming a moist gel, and cerium nitrate providing antimicrobial control. Colzen transforms into a transparent gel upon contact with the wound bed, which facilitates pain-free dressing changes and allows for continuous monitoring of the healing process. It is typically replaced every 72 hours and has intellectual property protection in multiple international markets.

Brand names
Colzen

Beyond the preview

Go deeper on Colzen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colzen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call